gene expression
Canhelp Genomics Partners With Mirxes Singapore to Offer Tumor Origin Identification Testing
The firms will make the Canhelp-Origin tumor identification test available for patients with cancers of unknown origin in some Southeast Asian countries.
Novigenix to Develop Prostate Cancer Liquid Biopsy Test With €1.8M Eurostars Consortium Grant
The company is working with investigators at Radboud University to validate an RNA liquid biopsy test to better tailor therapy in advanced castration-resistant prostate cancer.
New Data Shore Up Evidence for Paired Tumor Origin, Molecular Testing in Cancer of Unknown Primary
Premium
Biotheranostics' CancerType ID can predict tumor origins for the majority of CUP patients, with reflex biomarker testing finding those eligible for targeted treatment.
The firm is building a case for clinical utility of its gene expression test for cancer of unknown primary following a successful validation study.
Tumor Gene Expression Signature Linked to Chemotherapy Response in Colon Cancer Cases
Based on hundreds of stage II and III colon cancer samples, researchers uncovered and validated a 10-gene signature linked to adjuvant chemotherapy response.